David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Medicine Studies 1 (4):379-391 (2009)
PurposeSince the 1980s we have witnessed a soaring “extra-therapeutic” use of psycho-pharmacology. But there is also an increasing interest in invasive methods of neuroenhancement that can be subsumed under the term “brain engineering”. The present article aims to identify key issues raised by those forms of neuro-technical enhancement (e.g., deep brain stimulation, brain-computer interfaces, memory chips, neurobionic interventions). First it distinguishes different forms of neuroenhancement, then describes features of those methods and finally discusses their ethical implications.MethodsThe article is based on an in-depth literature study and an ethical assessment of the current and emerging forms of neuroenhancement.ResultsFrom a medical and normative perspective, psycho-pharmacological enhancement and nonpharmacological enhancement by brain engineering demonstrate considerable differences. Many arguments in favour of nonpharmacological enhancement fall short, for they fail to sufficiently consider the medical, anthropological and socio-cultural context. In many respects unsecured use is confronted with considerable risks.ConclusionsResearch on invasive forms of neuroenhancement partly takes place in the fields of (nano-)technology and military, to which health care experts and medical ethicists do not have easy access. This raises the danger of misjudging trends and developmental tendencies. Thus medicine and medical ethics must a priori thematize the goals and risks linked to these questions as well as participate discursively right from the beginning
|Keywords||Neurocognitive enhancement Nonpharmacological neuroenhancement Brain engineering Brain-computer interface Neurobionics Ethical key issues|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library||
References found in this work BETA
David Degrazia (2000). Prozac, Enhancement, and Self‐Creation. Hastings Center Report 30 (2):34-40.
Martha Farah (2001). Emerging Ethical Issues in Neuroscience. Nature Neuroscience 5:1123 - 1129.
Martha J. Farah (2005). Neuroethics: The Practical and the Philosophical. Trends in Cognitive Sciences 9 (1):34-40.
Walter Glannon (2006). Neuroethics. Bioethics 20 (1):37–52.
Matthis Synofzik (2005). Die neuen Möglichkeiten der Neurowissenschaften und ihre ethischen Implikationen. Ethik in der Medizin 17 (3):206-219.
Citations of this work BETA
Jakov Gather (2011). The Evaluation of Psychopharmacological Enhancers Beyond a Normative “Natural”–“Artificial” Dichotomy. Medicine Studies 3 (1):19-27.
Similar books and articles
A. E. Crawley (1934). ... Oath, Curse, and Blessing. London, Watts & Co..
Rami M. Shapiro (1989). Blessing and Curse. In S. Cromwell Crawford (ed.), World Religions and Global Ethics. Paragon House Publishers.
Anne Ruth Mackor (2009). Standardization of Spiritual Care in Healthcare Facilities in the Netherlands: Blessing or Curse? Ethics and Social Welfare 3 (2):215-228.
Matthis Synofzik (2009). Ethically Justified, Clinically Applicable Criteria for Physician Decision-Making in Psychopharmacological Enhancement. Neuroethics 2 (2):89-102.
Nick Bostrom (2009). Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW] Science and Engineering Ethics 15 (3):311-341.
Vincent Menuz, Thierry Hurlimann & Béatrice Godard (2013). Is Human Enhancement Also a Personal Matter? Science and Engineering Ethics 19 (1):161-177.
William Gardner (1995). Can Human Genetic Enhancement Be Prohibited? Journal of Medicine and Philosophy 20 (1):65-84.
Carissa Véliz (2011). Which Came First, the Chicken or the Egg? Rethinking Causal Directions Between Neural Mechanisms, Agency, and Human Enhancement. American Journal of Bioethics 2 (3):46-48.
Thomas Douglas (2008). Moral Enhancement. Journal of Applied Philosophy 25 (3):228-245.
W. French Anderson (1985). Human Gene Therapy: Scientific and Ethical Considerations. Journal of Medicine and Philosophy 10 (3):275-292.
Roger Whitehead & Scott D. Schliebner (2001). Arousal: Conscious Experience and Brain Mechanisms. In Peter G. Grossenbacher (ed.), Finding Consciousness in the Brain: A Neurocognitive Approach. John Benjamins. 187-220.
Dirk de Ridder (2007). Brain and Nerve Stimulation for Mood Enhancement. Philosophica 79:11-24.
Added to index2011-11-26
Total downloads5 ( #178,845 of 1,089,063 )
Recent downloads (6 months)1 ( #69,801 of 1,089,063 )
How can I increase my downloads?